OPTIMISING TSH RECEPTOR ANTIBODY (TRAB) TESTING IN PREGNANCY

A SINGLE-CENTRE AUDIT

Authors

  • Kausalyaa Krishnabalan
  • Azraai Bahari Nasruddin

Keywords:

TRAB, ATD, neonatal thyrotoxicosis

Abstract

INTRODUCTION
The course of Graves’ disease in pregnant women is variable and there is a risk of fetal/ neonatal thyrotoxicosis as TSH Receptor Antibodies (TRAb) can pass through the placenta. TRAb should be tested in pregnant patients with Grave's thyrotoxicosis or Grave's with a past history of radioiodine or thyroidectomy. The 2017 American Thyroid Association Thyroid Disease in Pregnancy Guideline specified a cut-off TRAb of >5 IU/L (3 times the upper limit of normal) in the first trimester to identify patients with increased risk. Patients with elevated TRAb in the first trimester and/ or requiring anti-thyroid drugs (ATD) mid-pregnancy are recommended for repeat testing in the third trimester. Persistent TRAb >5 IU/L in late pregnancy predicts risk of neonatal hyperthyroidism. We aimed to review the practice of TRAb monitoring in pregnancy in Hospital Putrajaya (HPJ).

METHODOLOGY
A retrospective audit of pregnant women with a history of Grave's thyrotoxicosis seen between 2019 to 2022 in HPJ. We identified 23 women with at least 2 TRAb tests in pregnancy.

RESULTS
Of 23 women, 19 were thyrotoxic on ATD, 3 were euthyroid on thyroxine replacement post-radioiodine therapy and 1 was euthyroid and without treatment. At baseline, 2 had normal TRAb (<1.75 IU/L), 13 had elevated TRAb but below the cut-off (>5 IU/L) and 8 significantly elevated TRAb (>5 IU/L). All 15 patients with initial TRAb below the cut-off, had repeat TRAb that remained either normal or below 5 IU/L. The TRAb level reduced to below 5 IU/L in 3 patients with initial high TRAb.

CONCLUSION
One patient had unnecessary initial testing and two-thirds of patients had unnecessary repeat TRAb testing. A TRAb level of <5 IU/L in early pregnancy correlated 100% with TRAb below the cut-off in late pregnancy. Overall, 1 in 5 women (21%) had risk of their fetus developing neonatal thyrotoxicosis. This audit highlights the need to improve awareness of the guidelines. A simple graphical algorithm has been developed as a guide.

Downloads

Download data is not yet available.

Author Biographies

Kausalyaa Krishnabalan

Endocrine Unit, Department of Medicine, Hospital Putrajaya, Putrajaya, Malaysia

Azraai Bahari Nasruddin

Endocrine Unit, Department of Medicine, Hospital Putrajaya, Putrajaya, Malaysia

References

*

Downloads

Published

2023-07-06

How to Cite

Krishnabalan , K., & Nasruddin, A. B. . (2023). OPTIMISING TSH RECEPTOR ANTIBODY (TRAB) TESTING IN PREGNANCY: A SINGLE-CENTRE AUDIT. Journal of the ASEAN Federation of Endocrine Societies, 38(S2), 18. Retrieved from https://asean-endocrinejournal.org/index.php/JAFES/article/view/3591

Issue

Section

Abstracts for Poster Presentation | Adult

Most read articles by the same author(s)